82 reports

It is also being evaluated for the treatment of Crohn' s disease, psoriatic arthritis, and asthma.

  • Chronic Pain
  • Forecast
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.

Physicians also avoid NSAIDs in surgeries that have no tolerance for bruising, patients with respiratory diseases such as asthma, nasal polyps and aspirin allergy.

  • Chronic Pain
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Chronic Pain
  • Vaccine
  • United States
  • Demand
  • Market Size

Rheumatoid arthritis

4546 5000 3864
  • PREVALENCE OF SELECTED CO-MORBIDITIES REPORTED IN THE INTERNATIONAL COMORA STUDY, BY REGION, 2014

In this study, patients were randomized ##:##:##:##:## to receive once-daily doses of placebo or ##mg, ##mg, ##mg, or ##mg baricitinib for ##weeks.

  • Chronic Pain
  • Japan
  • United States
  • Pfizer Inc.
  • Roche Group
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Chronic Pain
  • Forecast
  • Market Size
  • Smith & Nephew Plc
  • Zimmer Biomet Holdings, Inc.
  • 18.1 INTRODUCTION
  • SWITZERLAND HIP RECONSTRUCTION DEVICES MARKET, BY SURGERY TYPE,

IN THE U. K., ## IN ## WOMEN AND ## IN ## MEN SUFFER FRACTURES AFTER THE AGE OF ##.

  • Chronic Pain
  • South America
  • Forecast
  • Market Size
  • Zimmer Biomet Holdings, Inc.

IT AFFECTS ## IN ##, ## TO ## IN ##, ## BIRTHS.

  • Chronic Pain
  • Clinical Trial
  • Hospital
  • Nucleic Acid
  • GlobalData's company
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2017
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Chronic Pain
  • Clinical Trial
  • Therapy
  • Galapagos NV
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Arthritis
  • Cardiovascular Drug
  • Chronic Pain
  • Therapy
  • Can-Fite BioPharma Ltd.
  • Alphavirus Infections
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Chronic Pain
  • Clinical Trial
  • Therapy
  • World
  • Product Initiative

NO has a solid place in asthma management.

  • Drug Test
  • United States
  • Alere Inc.
  • Dräger Group
  • Thermo Fisher Scientific, Inc.
  • PIPELINE BY PARADIGM BIOPHARMACEUTICALS LTD, H1 2017
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H1 2017

The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ## and ## respectively.

  • Arthritis
  • Chronic Pain
  • Australia
  • Product Initiative
  • Galapagos NV
  • TOREFORANT TARTRATE

It was under development for the treatment of asthma.

  • Chronic Pain
  • Lymphoma
  • Monoclonal Antibody
  • Therapy
  • United States

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Chronic Pain
  • Hospital
  • Pharmaceutical
  • Therapy
  • Incyte Corporation
  • REJOIN - DRUG PROFILE
  • OSTEOARTHRITIS - DORMANT PROJECTS, H1 2018 (CONTD..4), H1 2018

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Arthritis
  • Cell Therapy
  • Chronic Pain
  • Therapy
  • Amgen Inc.
  • Number of Products under Development by Indication, H2 2017
  • Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2017

It is in preclinical stage for the treatment of allergic asthma and heart failure.

  • Chronic Pain
  • Clinical Trial
  • Therapy
  • Australia
  • Product Initiative
  • DORMANT PRODUCTS, H1 2018 (CONTD..1), H1 2018
  • DORMANT PRODUCTS, H1 2018 (CONTD..3), H1 2018

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Arthritis
  • Chronic Pain
  • Therapy
  • United States
  • Flex Pharma, Inc.

The molecules developed by Companies in Phase III, Phase II and Phase I stages are ##, ## and ## respectively.

  • Chronic Pain
  • Musculoskeletal Disorder
  • Pharmaceutical
  • Therapy
  • United States
  • DORMANT PRODUCTS, H2 2017 (CONTD..1), H2 2017
  • DORMANT PRODUCTS, H2 2017 (CONTD..3), H2 2017

Neurim offers treatments for other therapeutic areas that include Parkinson" s disease, and asthma or chronic obstructive pulmonary disease.

  • Chronic Pain
  • Pain Relief
  • United States
  • Product Initiative
  • Flex Pharma, Inc.
  • DORMANT PRODUCTS, H2 2017 (CONTD..4), H2 2017
  • PIPELINE BY PFIZER INC, H2 2017

The small molecules were also under development for asthma and rheumatoid arthritis.

  • Chronic Pain
  • Hospital
  • Therapy
  • United States
  • Product Initiative
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATIONS, H2 2017
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2017 (CONTD..1), H2 2017

It develops inhalation products, to help patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, pulmonary fibrosis and other diseases.

  • Chronic Pain
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.
  • PIPELINE BY PFIZER INC, H1 2018
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H1 2018

Regeneron also has various product candidates under clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Chronic Pain
  • United States
  • World
  • Product Initiative
  • Pfizer Inc.
  • R&D Progress
  • R&D Progress

The primary outcome measure of the study is to assess the improvement in the severity of asthma as measured by change in the asthma control questionnaire (ACQ) score.

  • Autoimmune Disease
  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • United States
  • INNOVIMMUNE BIOTHERAPEUTICS INC
  • INV-88 - DRUG PROFILE

Secondary endpoints include asthma exacerbation rate and the degree of asthma symptom control.

  • Cell Therapy
  • Chronic Pain
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.

ABBVIE IS ALSO EVALUATING THE POTENTIAL OF THIS BIOLOGIC IN CROHN' S DISEASE, PSORIATIC ARTHRITIS, AND ASTHMA.

  • Autoimmune Disease
  • Chronic Pain
  • United States
  • Company
  • Company Operations
  • DORMANT PRODUCTS, H1 2018 (CONTD..2), H1 2018
  • Tyrosine Protein Kinase JAK3 (Janus Kinase 3 or Leukocyte Janus Kinase or JAK3 or EC 2.7.10.2) - Dormant Products

Encore presentation from the WCOG at ACG2017 ##.

  • Chronic Pain
  • Therapy
  • United States
  • Product Initiative
  • Pfizer Inc.

Interleukin-##A (IL-##A) is a CD##+ T cell-derived cytokine that promotes inflammatory responses and is elevated in rheumatoid arthritis (RA), asthma, multiple sclerosis, psoriasis, and transplant rejection.

  • Autoimmune Disease
  • Chronic Pain
  • United States
  • Product Initiative
  • Novartis AG
  • R&D Progress
  • DALAZATIDE - DRUG PROFILE

AbbVie is also evaluating the potential of this biologic in Crohn' s disease, psoriatic arthritis, and asthma.

  • Autoimmune Disease
  • Biosimilar
  • Chronic Pain
  • United States
  • Product Initiative
  • PIPELINE BY REGENERON PHARMACEUTICALS INC, H2 2017

Regeneron is also developing various product candidates in clinical development for treating asthma, pain, cancer, atopic dermatitis and infectious diseases.

  • Chronic Pain
  • United States
  • World
  • Product Initiative
  • Pfizer Inc.
  • SYNTHETIC PEPTIDES FOR ALLERGIC ASTHMA AND RHEUMATOID ARTHRITIS - DRUG PROFILE
  • RHEUMATOID ARTHRITIS - PIPELINE BY ANGES MG INC, H1 2017

Rheumatoid Arthritis - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis - Pipeline Review, H1 2017, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape. Rheumatoid arthritis (RA) is an autoimmune...

  • Arthritis
  • Biosimilar
  • Chronic Pain
  • Pathology
  • Pfizer Inc.